Browse studies

Find your next paid study

1 recruiting study matching your filters

A Multicenter, Open-label Phase 1/2 Dose Finding, Safety, and Pharmacokinetic Study of MBRC-201, an Antibody-drug Conjugate, in Advanced Refractory Solid Tumors

This is a multicenter, open-label FIH, Phase 1a (dose escalation), Phase 1b (dose expansion) and Phase 2 study in patients with advanced metastatic solid tumor…

Prostate Cancer Castration-resistant Prostate CancerBreast CancerColo-rectal Cancer+2 more

MBrace TherapeuticsNCT07145255